| Date Filed | Type | Description |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 9,900 shares
@ $4.9994, valued at
$49.5k
|
|
| 01/23/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Bought 1,837 shares
@ $12.4549, valued at
$22.9k
Bought 63 shares
@ $12.4549, valued at
$784.7 |
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Bought 9,898 shares
@ $12.4993, valued at
$123.7k
Bought 338 shares
@ $12.4993, valued at
$4.2k
Bought 15,776 shares
@ $12.0021, valued at
$189.3k
Bought 538 shares
@ $12.0021, valued at
$6.5k
|
|
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Bought 1,208,750 shares
@ $10.6715, valued at
$12.9M
Bought 41,250 shares
@ $10.6715, valued at
$440.2k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
SC 13G/A
| COLUMN GROUP II, LP reports a 9.3% stake in ORIC PHARMACEUTICALS, INC. |
| 01/26/2022 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 241,750 shares
@ $0
Bought 8,250 shares
@ $0
Bought 579,910 shares
@ $0
Bought 19,791 shares
@ $0 |
|
| 11/16/2021 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Disposed of 1,200,000 shares
@ $0
Acquired 287,702 shares
@ $0
Disposed of 287,702 shares
@ $0
Acquired 86,716 shares
@ $0
Acquired 86,716 shares
@ $0
Acquired 74 shares
@ $0
Exercised 16,625 options to buy
@ $16, valued at
$266k
|
|
| 09/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2021 |
SC 13D/A
| COLUMN GROUP II, LP reports a 10.7% stake in RAPT THERAPEUTICS, INC. |
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|